borderline significantp = 0.04
We saw a borderline significant decrease in the risk of thyroid cancer associated with prior chemotherapy (HR = 0.52 (0.28–0.97); p = 0.04). 4.
We saw a borderline significant decrease in the risk of thyroid cancer associated with prior chemotherapy (HR = 0.52 (0.28–0.97); p = 0.04). 4.